Results 291 to 300 of about 102,703 (336)

The use of ROTEM in Detection of Coagulopathy and Altered Hemostasis in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. [PDF]

J Surg Oncol
Mashat A, Taqi K, Parapini M, Chen J, Trudeau J, Wilson J, Hamilton TD, MacNeill AJ.   +7 more
europepmc   +1 more source

Anastomosis versus rectal stump procedure in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal peritoneal metastases: A comparative study. [PDF]

Colorectal Dis
Ghanipour L, Mahmmud LO, Cashin P, Palmer GJ, Abraham-Nordling M.   +4 more
europepmc   +1 more source

Overall survival post secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent colorectal cancer with peritoneal metastases. [PDF]

World J Surg Oncol
Hayler R, Garrett C, Guo J, Barat S, Sarofim M, Wijayawardana R, Ahmadi N, Liauw W, Morris DL.   +8 more
europepmc   +1 more source

Robotic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is there a benefit? [PDF]

Surg Endosc
Sparkman BK, Freudenberger DC, Vudatha V, Trevino JG, Khader A, Fernandez LJ.   +5 more
europepmc   +1 more source

Nutrition Care for the Patient Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy. [PDF]

Sílvia Fernanda de Mendonça Figueirôa, Annette Dourney   +1 more
openalex  

Some of the next articles are maybe not open access.

Related searches:

INTRAPERITONEAL CHEMOTHERAPY

Obstetrics and Gynecology Clinics of North America, 1994
Despite high initial tumor response rates to systemically administered platinum-based chemotherapy, fewer than one quarter of advanced-stage ovarian cancer patients currently experience prolonged disease-free survival. Because persistent and relapsed disease tends to remain confined to the peritoneal cavity, the strategy of enhancing drug delivery to ...
Michael F. Flessner, Robert L. Dedrick
  +6 more sources

Intraperitoneal Chemotherapy with Melphalan

Annals of Internal Medicine, 1984
We administered melphalan by the intraperitoneal route to investigate its toxicity and pharmacokinetics. The drug was instilled with 2 litres of fluid and allowed to dwell in the peritoneal cavity for 4 hours. No local toxicity was detected by clinical examination, laboratory tests, or histologic examination.
S B, Howell, C E, Pfeifle, R A, Olshen
openaire   +2 more sources

Pharmacology of Intraperitoneal Chemotherapy

Cancer Investigation, 1983
In this review of the pharmacology and clinical application of intraperitoneal drug administration, we have tried to acquaint the reader with the current state of the art. At this juncture it is important to outline briefly some of the major remaining questions.
C E, Myers, J M, Collins
openaire   +2 more sources